Fused Ring STAT6 Inhibitor Scaffold for Allergic Inflammation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current technologies lack effective compounds that inhibit the activation and function of Signal Transducer and Activator of Transcription 6 (STAT6), which is crucial for treating inflammatory and allergic diseases associated with IL-4 and IL-13 signaling.
Innovation Solution
A novel compound expressed by general formula (I) with specific substituents and functional groups, including optionally substituted 5-membered heteroaryl, 5- to 6-membered non-aromatic heterocyclic, pyridonyl, or specific alkyl groups, exhibits excellent STAT6 inhibitory activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional compounds are used, then existing therapeutic effects are maintained, but STAT6 inhibitory activity is insufficient for effective treatment of inflammatory and allergic diseases
Solution Approach 1:
The patent modifies the chemical structure of conventional compounds by changing parameters such as substituting hydrogen atoms with halogen atoms (fluorine, chlorine, bromine), introducing specific functional groups (carboxyl, hydroxyl, amino), and adjusting molecular weight and lipophilicity parameters to achieve potent STAT6 inhibition while maintaining therapeutic effectiveness
Solution Approach 2:
The invention creates composite molecular structures by combining multiple functional groups and structural motifs within a single compound molecule, integrating STAT6 inhibitory pharmacophores with metabolic modulating groups to achieve both therapeutic effects and reduced side effects
2Reliability
If new STAT6 inhibitory compounds are developed, then therapeutic effectiveness is improved, but compound complexity and development difficulty increase
Solution Approach 1:
The patent divides the complex compound structure into distinct functional segments: a core scaffold providing STAT6 binding activity, substitutable side chains providing metabolic modulation, and optional functional groups providing additional therapeutic effects. This segmentation allows independent optimization of each component
Solution Approach 2:
The invention designs universal compound frameworks that can accommodate multiple substituents and functional groups, allowing a single core structure to generate multiple variants with different therapeutic profiles, reducing the need to develop entirely new compounds for different indications
3Ease of manufacture
If compound synthesis is simplified, then manufacturing ease is improved, but achieving potent STAT6 inhibition becomes more difficult
Solution Approach 1:
The patent employs preliminary action by using commercially available starting materials and established synthetic intermediates, building up to the final STAT6 inhibitory compound through a series of well-defined steps. Key intermediates are prepared in advance, and the synthesis route is designed to avoid complex multi-step sequences while maintaining structural complexity of the active compound
Data Source
AI summary
The present invention provides a novel compound that has STAT6 inhibitory activity and is effective for treatment of inflammatory diseases such as atopic dermatitis and for allergic diseases. A compound pharmaceutically acceptable salt thereof expressed by general formula (I) having STAT6 inhibitory activity.